Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 8,903,838 | 7,903,838 | -1,000,000 | $337.63M | $286.83M | 92.37% | -$50.80M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,167,114 | 1,429,014 | +261,900 | $13.74M | $23.71M | 7.63% | +$9.97M |